First and second generations of COX-2 selective inhibitors

被引：1
作者：
de Leval, X
Julémont, F
Benoit, V
Frederich, M
Pirotte, B
Dogné, JM
机构：
[1] Univ Liege, Nat & Synth Drugs Res Ctr, Dept Med Chem, Med Chem Lab, B-4000 Liege, Belgium
[2] Univ Liege, Cellular & Moll Therapeut Ctr, B-4000 Liege, Belgium
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 06期
关键词：
COX-2; inhibitors; selectivity; pre-clinical data;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
引用
收藏
页码：597 / 601
页数：5
相关论文
共 39 条
[11]   In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview [J].
Famaey, JP .
INFLAMMATION RESEARCH, 1997, 46 (11) :437-446
[12]   HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT [J].
FUNK, CD ;
FUNK, LB ;
KENNEDY, ME ;
PONG, AS ;
FITZGERALD, GA .
FASEB JOURNAL, 1991, 5 (09) :2304-2312
[13]   Anti-inflammatory activity of topical nimesulide gel in various experimental models [J].
Gupta, SK ;
Prakash, J ;
Awor, L ;
Joshi, S ;
Velpandian, T ;
Sengupta, S .
INFLAMMATION RESEARCH, 1996, 45 (12) :590-592
[14]   Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo [J].
Harris, SI ;
Kuss, M ;
Hubbard, RC ;
Goldstein, JL .
CLINICAL THERAPEUTICS, 2001, 23 (09) :1422-1428
[15]  
Henrotin YE, 1999, CLIN EXP RHEUMATOL, V17, P151
[16]   Characterization of celecoxib and valdecoxib binding to cyclooxygenase [J].
Hood, WF ;
Gierse, JK ;
Isakson, PC ;
Kiefer, JR ;
Kurumbail, RG ;
Seibert, K ;
Monahan, JB .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :870-877
[17]  
KAISER DG, 1967, J PHARMACOL EXP THER, V155, P174
[18]   Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes [J].
Kato, M ;
Nishida, S ;
Kitasato, H ;
Sakata, N ;
Kawai, S .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (12) :1679-1685
[19]   Interspecies differences in renal localization of cyclooxygenase isoforms: Implications in nonsteroidal antiinflammatory drug-related nephrotoxicity [J].
Khan, KNM ;
Venturini, CM ;
Bunch, RT ;
Brassard, JA ;
Koki, AT ;
Morris, DL ;
Trump, BF ;
Maziasz, TJ ;
Alden, CL .
TOXICOLOGIC PATHOLOGY, 1998, 26 (05) :612-620
[20]  
KUJUBU DA, 1991, J BIOL CHEM, V266, P12866
1234